Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renea A Taylor

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Pathology|June 13, 2017
A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumoursLucila Sackmann Sala, Florence Boutillon, Giulia Menara, et al.
British Journal of Cancer|November 20, 2025
Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomyYiyue Zhu, Elaheh Zarean, Danmeng L Li, et al.
BJU International|October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cellsLaura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Nature Communications|June 8, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancerZifeng Wang, Scott L Townley, Songqi Zhang, et al.
Molecular & Cellular Proteomics : MCP|May 8, 2019
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor MicroenvironmentElizabeth V Nguyen, Brooke A Pereira, Mitchell G Lawrence, et al.
Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Nature Reviews. Urology|January 17, 2023
The future of patient-derived xenografts in prostate cancer researchMitchell G Lawrence, Renea A Taylor, Georgia B Cuffe, et al.
Biomaterials|April 9, 2013
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancerAshlee K Clark, Anna V Taubenberger, Renea A Taylor, et al.
Science Translational Medicine|October 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft modelsXin Du, Pei K Goh, Chenkai Ma, et al.
Oncotarget|May 13, 2015
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeDamien A Leach, Eleanor F Need, Roxanne Toivanen, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Pathology|June 13, 2017
A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumoursLucila Sackmann Sala, Florence Boutillon, Giulia Menara, et al.
British Journal of Cancer|November 20, 2025
Tumour-based epigenetic signatures as markers of prostate cancer aggressiveness after radical prostatectomyYiyue Zhu, Elaheh Zarean, Danmeng L Li, et al.
BJU International|October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cellsLaura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Nature Communications|June 8, 2024
FOXA2 rewires AP-1 for transcriptional reprogramming and lineage plasticity in prostate cancerZifeng Wang, Scott L Townley, Songqi Zhang, et al.
Molecular & Cellular Proteomics : MCP|May 8, 2019
Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor MicroenvironmentElizabeth V Nguyen, Brooke A Pereira, Mitchell G Lawrence, et al.
Molecular Cancer Therapeutics|August 20, 2021
CX-5461 Sensitizes DNA Damage Repair-proficient Castrate-resistant Prostate Cancer to PARP InhibitionMitchell G Lawrence, Laura H Porter, Nicholas Choo, et al.
Nature Reviews. Urology|January 17, 2023
The future of patient-derived xenografts in prostate cancer researchMitchell G Lawrence, Renea A Taylor, Georgia B Cuffe, et al.
Biomaterials|April 9, 2013
A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancerAshlee K Clark, Anna V Taubenberger, Renea A Taylor, et al.
Science Translational Medicine|October 29, 2025
Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft modelsXin Du, Pei K Goh, Chenkai Ma, et al.
Oncotarget|May 13, 2015
Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcomeDamien A Leach, Eleanor F Need, Roxanne Toivanen, et al.
Pageof 9